Clinical Trial Update: Growth Hormone Treatment Study in Children With Cystic Fibrosis [Phase 2, Phase 3]

View source ↗

Summary

A growth hormone treatment trial in children with cystic fibrosis was withdrawn after Phase 2/3 enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Cystic Fibrosis | Phase 2, Phase 3 | Status: WITHDRAWN